NK cells: A double-edged sword in chronic hepatitis B virus infection

Frontiers in Immunology

Volumn 4, Issue MAR, 2013, Pages

  Maini, Mala K ^a   Peppa, Dimitra ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

CD56bright; Hepatitis B virus; IFN alfa; IL 10; Interferon gamma; Liver damage; NK cells; TRAIL

Indexed keywords

ALPHA INTERFERON; CHEMOKINE RECEPTOR CXCR6; DEATH RECEPTOR 5; ECALECTIN; FAS LIGAND; GAMMA INTERFERON; GRANZYME; I KAPPA B KINASE GAMMA; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; PEPTIDES AND PROTEINS; PERFORIN; SIGNALING LYMPHOCYTE ACTIVATION MOLECULE ASSOCIATED PROTEIN; T CELL IMMUNOGLOBULIN AND MUCIN DOMAIN CONTAINING MOLECULE 3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

APOPTOSIS; CELL INFILTRATION; HEPATITIS B; HUMAN; INFLAMMATION; LIVER INJURY; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; REVIEW; UPREGULATION; VIRAL CLEARANCE; VIRUS LOAD;

EID: 84883746075     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00057     Document Type: Review

References (75)

1. Ahlenstiel, G., Edlich, B., Hogdal, L. J., Rotman, Y., Noureddin, M., Feld, J. J., et al. (2011). Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C. Gastroenterology 141, 1231-1239, 1239.e1-1239.e2.
2. Alter, G., Heckerman, D., Schneidewind, A., Fadda, L., Kadie, C. M., Carlson, J. M., et al. (2011). HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476, 96-100.
3. Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., et al. (2007). Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204, 3027-3036.
4. Ando, K., Moriyama, T., Guidotti, L. G., Wirth, S., Schreiber, R. D., Schlicht, H. J., et al. (1993). Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541-1554.
5. Balkow, S., Kersten, A., Tran, T. T., Stehle, T., Grosse, P., Museteanu, C., et al. (2001). Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J. Virol. 75, 8781-8791.
6. Beraza, N., Malato, Y., Sander, L. E., Al-Masaoudi, M., Freimuth, J., Riethmacher, D., et al. (2009). Hepatocyte-specific NEMO deletion promotes NK/NKT cell- and TRAIL-dependent liver damage. J. Exp. Med. 206, 1727-1737.
7. Burt, B. M., Plitas, G., Zhao, Z., Bamboat, Z. M., Nguyen, H. M., Dupont, B., et al. (2009). The lytic potential of human liver NK cells is restricted by their limited expression of inhibitory killer Ig-like receptors. J. Immunol. 183, 1789-1796.
8. Chen, Y., Wei, H., Sun, R., Dong, Z., Zhang, J., and Tian, Z. (2007). Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 46, 706-715.
9. Crispe, I. N. (2009). The liver as a lymphoid organ. Annu. Rev. Immunol. 27, 147-163.
10. Das, A., Ellis, G., Pallant, C., Lopes, A. R., Khanna, P., Peppa, D., et al. (2012). IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J. Immunol. 189, 3925-3935.
11. Doherty, D. G., Norris, S., Madrigal-Estebas, L., McEntee, G., Traynor, O., Hegarty, J. E., et al. (1999). The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 163, 2314-2321.
12. Dunn, C., Brunetto, M., Reynolds, G., Christophides, T., Kennedy, P. T., Lampertico, P., et al. (2007). Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J. Exp. Med. 204, 667-680.
13. Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., et al. (2009). Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 1289-1300.
14. Fang, J. W., Shen, W. W., Meager, A., and Lau, J. Y. (1996). Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection. Am. J. Gastroenterol. 91, 748-753.
15. Fisicaro, P., Valdatta, C., Boni, C., Massari, M., Mori, C., Zerbini, A., et al. (2009). Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58, 974-982.
16. Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., et al. (1995). Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
17. Glassner, A., Eisenhardt, M., Kramer, B., Korner, C., Coenen, M., Sauerbruch, T., et al. (2012). NK cells from HCV-infected patients effectively induce apoptosis of activated primary human hepatic stellate cells in a TRAIL-, FasL- and NKG2D-dependent manner. Lab. Invest. 92, 967-977.
18. Guidotti, L. G., Ishikawa, T., Hobbs, M. V., Matzke, B., Schreiber, R., and Chisari, F. V. (1996). Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4, 25-36.
19. Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R., and Chisari, F. V. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-829.
20. Guy, C. S., Mulrooney-Cousins, P. M., Churchill, N. D., and Michalak, T. I. (2008). Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J. Virol. 82, 8579-8591.
21. Huang, M., Sun, R., Wei, H., and Tian, Z. (2013). Simultaneous knockdown of multiple ligands of innate receptor NKG2D high efficiently prevents NK cell-mediated fulminant hepatitis. Hepatology 57, 277-288.
22. Ishiyama, K., Ohdan, H., Ohira, M., Mitsuta, H., Arihiro, K., and Asahara, T. (2006). Difference in cytotoxicity against hepatocellular carcinoma between liver and periphery natural killer cells in humans. Hepatology 43, 362-372.
23. Janssen, H. L., Higuchi, H., Abdulkarim, A., and Gores, G. J. (2003). Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression. J. Hepatol. 39, 414-420.
24. Ju, Y., Hou, N., Meng, J., Wang, X., Zhang, X., Zhao, D., et al. (2010). T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52, 322-329.
25. Kafrouni, M. I., Brown, G. R., and Thiele, D. L. (2001). Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. J. Immunol. 167, 1566-1574.
26. Kakimi, K., Guidotti, L. G., Koezuka, Y., and Chisari, F. V. (2000). Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930.
27. Kakimi, K., Lane, T. E., Wieland, S., Asensio, V. C., Campbell, I. L., Chisari, F. V., et al. (2001). Blocking chemokine responsive to gamma-2/interferon (IFN)-gamma inducible protein and monokine induced by IFN-gamma activity in vivo reduces the pathogenetic but not the antiviral potential of hepatitis B virus-specific cytotoxic T lymphocytes. J. Exp. Med. 194, 1755-1766.
28. Kamimura, H., Yamagiwa, S., Tsuchiya, A., Takamura, M., Matsuda, Y., Ohkoshi, S., et al. (2012). Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence. J. Hepatol. 56, 381-388.
29. Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., et al. (2004). HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874.
30. Lang, P. A., Lang, K. S., Xu, H. C., Grusdat, M., Parish, I. A., Recher, M., et al. (2012). Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc. Natl. Acad. Sci. U.S.A. 109, 1210-1215.
31. Lassen, M. G., Lukens, J. R., Dolina, J. S., Brown, M. G., and Hahn, Y. S. (2010). Intrahepatic IL-10 maintains NKG2A+Ly49-liver NK cells in a functionally hyporesponsive state. J. Immunol. 184, 2693-2701.
32. Lee, S. H., Miyagi, T., and Biron, C. A. (2007). Keeping NK cells in highly regulated antiviral warfare. Trends Immunol. 28, 252-259.
33. Liang, X., Liu, Y., Zhang, Q., Gao, L., Han, L., Ma, C., et al. (2007). Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J. Immunol. 178, 503-510.
34. Maini, M. K., Boni, C., Lee, C. K., Larrubia, J. R., Reignat, S., Ogg, G. S., et al. (2000). The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J. Exp. Med. 191, 1269-1280.
35. Malhi, H., and Gores, G. J. (2008). Cellular and molecular mechanisms of liver injury. Gastroenterology 134, 1641-1654.
36. Martin, M. P., Gao, X., Lee, J. H., Nelson, G. W., Detels, R., Goedert, J. J., et al. (2002). Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429-434.
37. Micco, L., Peppa, D., Loggi, E., Schurich, A., Jefferson, L., Cursaro, C., et al. (2013). Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. J. Hepatol. 58, 225-233.
38. Mizuhara, H., O'Neill, E., Seki, N., Ogawa, T., Kusunoki, C., Otsuka, K., et al. (1994). T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J. Exp. Med. 179, 1529-1537.
39. Moroso, V., Famili, F., Papazian, N., Cupedo, T., van der Laan, L. J., Kazemier, G., et al. (2011). NK cells can generate from precursors in the adult human liver. Eur. J. Immunol. 41, 3340-3350.
40. Nebbia, G., Peppa, D., Schurich, A., Khanna, P., Singh, H. D., Cheng, Y., et al. (2012). Upregulation of the Tim-3/galectin-9 pathway of T cell exhaustion in chronic hepatitis B virus infection. PLoS ONE 7:e47648. doi:10.1371/journal.pone.0047648
41. Nuti, S, Rosa, D., Valiante, N. M., Saletti, G., Caratozzolo, M., Dellabona, P., et al. (1998). Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28, 3448-3455.
42. Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., et al. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
43. Okazaki, A., Hiraga, N., Imamura, M., Hayes, C. N., Tsuge, M., Takahashi, S., et al. (2012). Severe necroinflammatory reaction caused by natural killer cell-mediated Fas/Fas ligand interaction and dendritic cells in human hepatocyte chimeric mouse. Hepatology 56, 555-566.
44. Oliviero, B., Varchetta, S., Paudice, E., Michelone, G., Zaramella, M., Mavilio, D., et al. (2009). Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 137, 1151-1160.
45. Orange, J. S., Fassett, M. S., Koopman, L. A., Boyson, J. E., and Strominger, J. L. (2002). Viral evasion of natural killer cells. Nat. Immunol. 3, 1006-1012.
46. Papatheodoridis, G. V., Manolakopoulos, S., Dusheiko, G., and Archimandritis, A. J. (2008). Therapeutic strategies in the management of patients with chronic hepatitis B virus infection. Lancet Infect. Dis. 8, 167-178.
47. Paust, S., Gill, H. S., Wang, B. Z., Flynn, M. P., Moseman, E. A., Senman, B., et al. (2010). Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11, 1127-1135.
48. Peppa, D., Gill, U. S., Reynolds, G., Easom, N. J., Pallett, L. J., Schurich, A., et al. (2013). Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J. Exp. Med. 210, 99-114.
49. Peppa, D., Micco, L., Javaid, A., Kennedy, P. T., Schurich, A., Dunn, C., et al. (2010). Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection. PLoS Pathog. 6:e1001227. doi:10.1371/journal.ppat.1001227
50. Protzer, U, Maini, M. K., and Knolle, P. A. (2012). Living in the liver: hepatic infections. Nat. Rev. Immunol. 12, 201-213.
51. Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z., and Gao, B. (2006). Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners. Gastroenterology 130, 435-452.
52. Saitou, Y., Shiraki, K., Fuke, H., Inoue, T., Miyashita, K., Yamanaka, Y., et al. (2005). Involvement of tumor necrosis factor-related apoptosis-inducing ligand and tumor necrosis factor-related apoptosis-inducing ligand receptors in viral hepatic diseases. Hum. Pathol. 36, 1066-1073.
53. Salazar-Mather, T. P., Orange, J. S., and Biron, C. A. (1998). Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J. Exp. Med. 187, 1-14.
54. Sarhan, D., D'Arcy, P., Wennerberg, E., Liden, M., Hu, J., Winqvist, O., et al. (2012). Activated monocytes augment TRAIL-mediated cytotoxicity by human NK cells through release of IFN-gamma. Eur. J. Immunol. 43, 249-257.
55. Schmich, K., Schlatter, R., Corazza, N., Sa Ferreira, K., Ederer, M., Brunner, T., et al. (2011). Tumor necrosis factor alpha sensitizes primary murine hepatocytes to Fas/CD95-induced apoptosis in a Bim- and Bid-dependent manner. Hepatology 53, 282-292.
56. Shi, C. C., Tjwa, E. T., Biesta, P. J., Boonstra, A., Xie, Q., Janssen, H. L., et al. (2012). Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells. J. Viral Hepat. 19, e26-e33.
57. Shi, F. D., Ljunggren, H. G., La Cava, A., and Van Kaer, L. (2011). Organ-specific features of natural killer cells. Nat. Rev. Immunol. 11, 658-671.
58. Sprengers, D., van der Molen, R. G., Kusters, J. G., Hansen, B., Niesters, H. G., Schalm, S. W., et al. (2006). Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B. J. Med. Virol. 78, 561-568.
59. Stegmann, K. A., Bjorkstrom, N. K., Veber, H., Ciesek, S., Riese, P., Wiegand, J., et al. (2010). Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 138, 1885-1897.
60. Stockinger, B. (2009). Immunology: cause of death matters. Nature 458, 44-45.
61. Sun, C., Fu, B., Gao, Y., Liao, X., Sun, R., Tian, Z., et al. (2012). TGF-beta1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence. PLoS Pathog. 8:e1002594. doi:10.1371/journal.ppat.1002594
62. Takeda, K, Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., et al. (2001). Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7, 94-100.
63. Tay, C. H., and Welsh, R. M. (1997). Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J. Virol. 71, 267-275.
64. Thimme, R., Wieland, S., Steiger, C., Ghrayeb, J., Reimann, K. A., Purcell, R. H., et al. (2003). CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J. Virol. 77, 68-76.
65. Tjwa, E. T., van Oord, G. W., Hegmans, J. P., Janssen, H. L., and Woltman, A. M. (2011). Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J. Hepatol. 54, 209-218.
66. Tu, Z., Bozorgzadeh, A., Pierce, R. H., Kurtis, J., Crispe, I. N., and Orloff, M. S. (2008). TLR-dependent cross talk between human Kupffer cells and NK cells. J. Exp. Med. 205, 233-244.
67. Waggoner, S. N., Cornberg, M., Selin, L. K., and Welsh, R. M. (2012). Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394-398.
68. Waggoner, S. N., Taniguchi, R. T., Mathew, P. A., Kumar, V., and Welsh, R. M. (2010). Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis. J. Clin. Invest. 120, 1925-1938.
69. Webster, G. J., Reignat, S., Maini, M. K., Whalley, S. A., Ogg, G. S., King, A., et al. (2000). Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117-1124.
70. Wohlleber, D., Kashkar, H., Gartner, K., Frings, M. K., Odenthal, M., Hegenbarth, S., et al. (2012). TNF-induced target cell killing by CTL activated through cross-presentation. Cell Rep. 2, 478-487.
71. Yang, P. L., Althage, A., Chung, J., and Chisari, F. V. (2002). Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc. Natl. Acad. Sci. U.S.A. 99, 13825-13830.
72. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M., and Flavell, R. A. (2007). Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647-659.
73. Zhang, Z., Zhang, S., Zou, Z., Shi, J., Zhao, J., Fan, R., et al. (2011). Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology 53, 73-85.
74. Zheng, S. J., Wang, P., Tsabary, G., and Chen, Y. H. (2004). Critical roles of TRAIL in hepatic cell death and hepatic inflammation. J. Clin. Invest. 113, 58-64.
75. Zou, Y., Chen, T., Han, M., Wang, H., Yan, W., Song, G., et al. (2010). Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J. Immunol. 184, 466-475.